Výsledky vyhledávání

Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay

Autor: C. Anthony Blau, Jodie David, Elihu H. Estey, Sylvia Chien, Timothy J. Martins, Fabiana Ostronoff, Vivian G. Oehler, Andrea M. Perdue, Paul C. Hendrie, Pamela S. Becker

Publikováno v: Blood. 124:3748-3748

Introduction. Resistance to therapy, rather than treatment-related mortality, is the usual cause of failure to cure AML. Typically all patients receive the same therapy despite great inter-patient variation in the mutations that underlie the disease.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4c50ad54913d223fd5502d2030b3e7e
https://doi.org/10.1182/blood.v124.21.3748.3748

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání